Scholars@Duke
Daniel Edmonston

Daniel Edmonston

Assistant Professor of Medicine
Medicine, Nephrology

Overview

My primary research focus lies at the intersection of kidney and cardiovascular disease including pulmonary hypertension, heart failure, and atherosclerotic disease in patients with chronic kidney disease.

Current Duke Appointments & Affiliations

Assistant Professor of Medicine · 2021 - Present Medicine, Nephrology, Medicine
Member in the Duke Clinical Research Institute · 2019 - Present Duke Clinical Research Institute, Institutes and Centers

Recent News Items

Published October 10, 2025
VuMedi
CKD in T2D: Evaluating Concordance With Screening and Treatment Guidelines
Published July 10, 2025
HealthDay
Few with type 2 diabetes receive guideline-recommended CKD screening
Published August 19, 2024
tctMD
Both SGLT2 and GLP-1 Drugs Help Heart and Kidneys in Type 2 Diabetes

View All News Items

Recent Scholarly Works

Perioperative management of patients taking sodium-glucose cotransporter 2 inhibitors: Society for Perioperative Assessment and Quality Improvement (SPAQI) multidisciplinary consensus statement.

Journal article Br J Anaesth · June 2026 The perioperative management of patients using sodium-glucose cotransporter 2 inhibitors (SGLT2is) remains controversial. The US Food and Drug Administration currently recommends stopping SGLT2is for 3-4 days before surgery, irrespective of a diagnosis of ... Full text Link to item Cite

Impact of Treatment Modalities on Intensive Care Unit Length of Stay for Patients Admitted With Severe Hyponatremia.

Conference Ann Pharmacother · May 2026 BACKGROUND: The diversity in presentation and cause of hyponatremia leads to a wide array of treatment modalities which are selected based on severity, chronicity, volume status, and putative cause. Due to the variability in treatment selection, it is pert ... Full text Link to item Cite
View All Scholarly Works

Recent Grants

TRIO NRSA Training Core-Post Doc Trainee

Inst. Training Prgm or CMEMentor · Awarded by University of North Carolina - Chapel Hill · 2023 - 2028

Novel Mechanisms and Therapeutic Targets for Pulmonary Hypertension in End-Stage Renal Disease (K23)

ResearchPrincipal Investigator · Awarded by National Heart, Lung, and Blood Institute · 2021 - 2027

The Role of Klotho and Serotonin in Cardiovascular Outcomes and Mortality in CKD

ResearchCo-Principal Investigator · Awarded by University of Pennsylvania · 2021 - 2024

View All Grants

Education

Mercer University, School of Medicine · 2013 M.D.